West Pharmaceutical Services, Inc. is rated a Hold due to exemplary dividend safety and a fortress balance sheet. Read more ...
US biotech Regeneron Pharmaceuticals has announced financial results for the first quarter of 2026 and provided a business ...
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) ranks among the most profitable biotech stocks to buy now. Following comments on ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
A UK biotech company has launched what it describes as a world‑first platform of lab‑grown human muscle designed to give drug ...
A phase 2 trial of Indivior Pharmaceuticals’ opioid use disorder (OUD) candidate has missed its primary endpoint. Indivior ...
CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Answering 'how large is our addressable patient pool?' shouldn't take weeks. DelveInsight's DelveEpiAI, an AI-driven epidemiology database, delivers validated, analyst-grade insights instantly, so ...
Bristol Myers Squibb has called time on a bispecific antibody partnership with Zymeworks that the Big Pharma inherited from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results